F Freymuth (Professeur de virologie, biologiste des hôpitaux)
{"title":"Infections à virus respiratoire syncytial et virus para-influenza : prévention et traitement","authors":"F Freymuth (Professeur de virologie, biologiste des hôpitaux)","doi":"10.1016/j.emcped.2003.06.004","DOIUrl":null,"url":null,"abstract":"<div><p>Controlling the dissemination to children of the respiratory syncytial virus (RSV) and parainfluenzae virus (PIV) rests mainly on simple hygiene measures such as hand washing and contact precautions. In addition to the nonspecific treatment of bronchiolitis (chest physiotherapy), ribavirin, an antiviral agent active against the RSV and PIV in vitro, is used in clinical practice only by inhalation in severe forms of RSV infection. Anti-RSV immune globulins have been proved effective in preventing RSV infection or its severe forms. The humanized monoclonal antibody palivizumab is used in France in selected patients.</p></div>","PeriodicalId":100441,"journal":{"name":"EMC - Pédiatrie","volume":"1 1","pages":"Pages 28-32"},"PeriodicalIF":0.0000,"publicationDate":"2004-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.emcped.2003.06.004","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"EMC - Pédiatrie","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1762601303000120","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Controlling the dissemination to children of the respiratory syncytial virus (RSV) and parainfluenzae virus (PIV) rests mainly on simple hygiene measures such as hand washing and contact precautions. In addition to the nonspecific treatment of bronchiolitis (chest physiotherapy), ribavirin, an antiviral agent active against the RSV and PIV in vitro, is used in clinical practice only by inhalation in severe forms of RSV infection. Anti-RSV immune globulins have been proved effective in preventing RSV infection or its severe forms. The humanized monoclonal antibody palivizumab is used in France in selected patients.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
